Is SNAVF or MRK a better dividend investment in 2026?

SNAVF currently yields 62500.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SNAVF offers higher current income.

What is the dividend yield difference between SNAVF and MRK?

SNAVF has a forward dividend yield of 62500.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 62497.24 percentage points.

Home › Compare › SNAVF vs MRK

SNAVF vs MRK: Dividend Comparison 2026

SNAVF yields 62500.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SNAVF wins by $4.4339448941250405e+24M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SNAVF

● Live price

62500.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.4339448941250405e+24M

Annual income

$4,420,033,095,559,928,000,000,000,000,000.00

Full SNAVF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SNAVF vs MRK

📍 SNAVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SNAVF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SNAVF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SNAVF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNAVF

Annual income on $10K today (after 15% tax)

$5,312,500.00/yr

After 10yr DRIP, annual income (after tax)

$3,757,028,131,225,939,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SNAVF beats the other by $3,757,028,131,225,939,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNAVF + MRK for your $10,000?

SNAVF: 50%MRK: 50%

100% MRK50/50100% SNAVF

Portfolio after 10yr

$2.2169724470625202e+24M

Annual income

$2,210,016,547,779,964,000,000,000,000,000.00/yr

Blended yield

99.69%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SNAVF

No analyst data

Altman Z

-182.4

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNAVF buys

MRK buys

No recent congressional trades found for SNAVF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSNAVFMRK

Forward yield	62500.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4.4339448941250405e+24M	$56.8K ✓
Annual income after 10y	$4,420,033,095,559,928,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$4.4330322753903105e+24M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SNAVF vs MRK ($10,000, DRIP)

Year	SNAVF Portfolio	SNAVF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$6,260,700	$6,250,000.00	$11,206	$366.19	+$6.25M → SNAVF
2	$3,663,649,884	$3,656,950,934.58	$12,650	$502.35	+$3663.64M → SNAVF
3	$2,003,903,664,845	$1,999,983,559,469.95	$14,407	$694.19	+$2003903.65M → SNAVF
4	$1,024,508,118,863,311	$1,022,363,941,941,926.80	$16,585	$967.82	+$1024508118.85M → SNAVF
5	$489,591,435,302,581,700	$488,495,211,615,398,100.00	$19,342	$1,363.89	+$489591435302.56M → SNAVF
6	$218,693,817,188,469,540,000	$218,169,954,352,695,770,000.00	$22,913	$1,947.19	+$218693817188469.50M → SNAVF
7	$91,312,080,184,570,770,000,000	$91,078,077,800,179,120,000,000.00	$27,662	$2,823.89	+$91312080184570768.00M → SNAVF
8	$35,638,062,904,476,556,000,000,000	$35,540,358,978,679,070,000,000,000.00	$34,159	$4,173.35	+$35638062904476557312.00M → SNAVF
9	$13,001,680,901,974,605,000,000,000,000	$12,963,548,174,666,812,000,000,000,000.00	$43,337	$6,308.80	+$1.3001680901974606e+22M → SNAVF
10	$4,433,944,894,125,040,400,000,000,000,000	$4,420,033,095,559,928,000,000,000,000,000.00	$56,776	$9,798.13	+$4.4339448941250405e+24M → SNAVF

SNAVF vs MRK: Complete Analysis 2026

SNAVF — Stock

Star Navigation Systems Group Ltd. develops, markets, and sells in-flight safety monitoring systems (ISMS) worldwide. The company provides STAR-ISMS, an aircraft computer that combines in-flight data monitoring, diagnostics, and data analysis with real time connections between the aircraft and the ground using real-time satellite transmission. It also offers STAR airborne data service that offers real-time monitoring, data analysis, aircraft health and flight operation status, and real-time position information. In addition, the company provides STAR-M.M.I. that repairs, performs qualification tests, and supports onboard LCD flat screen displays for cockpits of fixed wing aircraft and helicopters for civilian and military applications. The company was founded in 2000 and is headquartered in Brampton, Canada.

Full SNAVF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SNAVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNAVF vs SCHD SNAVF vs JEPI SNAVF vs O SNAVF vs KO SNAVF vs MAIN SNAVF vs JNJ SNAVF vs ABBV SNAVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.